Zobrazeno 1 - 10
of 86
pro vyhledávání: '"Stefan Vitko"'
Autor:
Mario Vilatobá, Gaohong Dong, Lionel Rostaing, Maarten H. L. Christiaans, Elisabeth Cassuto, Kazimierz Ciechanowski, Guido Junge, Uwe Machein, Helio Tedesco-Silva, Bettina Ulbricht, Stefan Vitko, Ronald J. Hené, Robert M. Langer, Julio Pascual
Publikováno v:
Transplant International. 25:592-602
There is increasing interest in tacrolimus-minimization regimens. ASSET was an open-label, randomized, 12-month study of everolimus plus tacrolimus in de-novo renal-transplant recipients. Everolimus trough targets were 3-8 ng/ml throughout the study.
Autor:
Henrik Ekberg, Pierre Daloze, Stefan Vitko, Izzet Titiz, Rafael Reyes-Acevedo, Corrado Bernasconi, Ulrich Frei, Lutz Fricke, Juergen Klempnauer
Publikováno v:
Clinical Transplantation. 24:500-509
The Symphony study assessed whether mycophenolate mofetil (MMF)-based regimens containing reduced doses of adjunct immunosuppressants could reduce toxicity while maintaining efficacy. Here, we examined the impact of acute rejection and associated ris
Autor:
Uwe Heemann, Tobias R. Türk, Stefan Vitko, Ondrej Viklicky, Jens Lutz, Isabel Willenberg, Oliver Witzke, Benjamin Wilde
Publikováno v:
Langenbeck's Archives of Surgery. 394:1073-1078
The purpose of this study was to analyse the outcome and its influencing factors in patients whose therapy was converted from calcineurin inhibitors (CNI) to sirolimus (SRL) due to chronic allograft nephropathy (CAN). Therapies of 78 patients (44 men
Autor:
Otto Schück, Dalibor Lecian, Stefan Vitko, Jaroslav Racek, Vladimír Teplan, Michal Kudla, Martin Haluzik
Publikováno v:
Journal of Renal Nutrition. 18:513-520
We have assessed in obese renal transplant recipients a course of selected proinflammatory factors liable to influence the long-term outcome of transplant patients and kidney grafts.In a prospective cohort study, we examined a total of 68 obese renal
Autor:
Martin Haluzik, Jaroslav Racek, Otto Schück, Michal Kudla, Stefan Vitko, Vladimír Teplan, Romana Siroka
Publikováno v:
Journal of Renal Nutrition. 18:154-157
In obese renal transplant recipients, we assessed the course of selected proinflammatory factors liable to influence long-term outcomes of transplant patients and kidney grafts.In a prospective cohort study, we examined a total of 140 renal transplan
Publikováno v:
Kidney and Blood Pressure Research. 31:196-202
Background: Post-transplant osteopathy is a known complication of kidney transplantation (KTx). The aim of this study was to assess bone mineral density (BMD) in a large cohort of patients with treatment depending on pre-transplant pa-rathormone (PTH
Autor:
Ulrich Frei, Yves Vanrenterghem, Henrik Ekberg, Christian Hugo, A Guerkan, Pierre Daloze, Stefan Vitko, J. M. Grinyo, P Halloran, Raimund Margreiter, Alper Demirbas, Helio Tedesco-Silva, Juergen Klempnauer
Publikováno v:
Transplant International. 20:2-39
Autor:
Petra Hribova, Jelena Skibova, J. Lacha, Irena Brabcova, Katja Kotsch, Stefan Vitko, Ondrej Viklicky, Hans-Dieter Volk
Publikováno v:
Kidney and Blood Pressure Research. 30:273-282
Aims: Proinflammatory cytokines are thought to play an important role in various kidney graft diseases resulting in interstitial fibrosis and tubular atrophy frequently found in case biopsies. To explore the role of various cytokines and chemokines i
Autor:
Lorenzo Gallon, Helio Tedesco-Silva, Earnst H Scheuermann, Dean Fergusson, Madzouka B. Kokolo, Henrik Ekberg, Robin Ducharme, Ahmed Morsy, Chieny Buenaventura, Greg Knoll, Tom Blydt-Hansen, Markus Guba, Stefan Vitko, Corrado Bernasconi, Jan Gossmann, Rebekka Salgo, Denis Glotz, Claudia Rosso Felipe, Ranjeeta Mallick, Rashad S. Barsoum, Andrew H. Beck, M. Gelens, John Firth, Christopher J.E. Watson
Publikováno v:
BMJ (e), 349:g6679. BMJ Publishing Group
Objective: To examine risk of malignancy and death in patients with kidney transplant who receive the immunosuppressive drug sirolimus. Design: Systematic review and meta-analysis of individual patient data. Data sources: Medline, Embase, and the Coc
Autor:
Peter Wijngaard, Nesrin Gafner, Daniel Abramowicz, Derek Manas, Domingo Del Castillo, Stefan Vitko, Maria del Carmen Rial, Mieczyslaw Lao
Publikováno v:
Journal of the American Society of Nephrology. 16:2234-2240
Maintenance immunosuppression with cyclosporine (CsA) is associated with nephrotoxicity, hyperlipidemia, and hypertension. This long-term study (core study + 4 yr of follow-up) investigated the long-term efficacy and safety of CsA withdrawal from a m